Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hüttner A[au]:

New and improved? A review of novel antibiotics for Gram-positive bacteria. Abbas M et al. Clin Microbiol Infect. (2017)

Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage. Chang CF et al. J Clin Invest. (2018)

Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice. Jurado KA et al. Nat Microbiol. (2018)

Search results

Items: 1 to 50 of 98

1.

Charge transfer processes and carrier dynamics at the pentacene - C60 interface.

Döring RC, Rosemann NW, Huttner A, Breuer T, Witte G, Chatterjee S.

J Phys Condens Matter. 2019 Jan 15. doi: 10.1088/1361-648X/aafea7. [Epub ahead of print]

PMID:
30645985
2.

Cefiderocol for treatment of complicated urinary tract infections - Author's reply.

Huttner A.

Lancet Infect Dis. 2019 Jan;19(1):24-25. doi: 10.1016/S1473-3099(18)30728-X. No abstract available.

PMID:
30587291
3.

Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study.

Bricheux A, Lenggenhager L, Hughes S, Karmime A, Lescuyer P, Huttner A.

Clin Microbiol Infect. 2018 Dec 4. pii: S1198-743X(18)30749-3. doi: 10.1016/j.cmi.2018.11.020. [Epub ahead of print]

PMID:
30528370
4.

Cefiderocol in context.

Huttner A.

Lancet Infect Dis. 2018 Dec;18(12):1290-1291. doi: 10.1016/S1473-3099(18)30615-7. Epub 2018 Oct 25. No abstract available.

PMID:
30509674
5.

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Huttner A, Siegrist CA.

Expert Rev Vaccines. 2018 Dec;17(12):1105-1110. doi: 10.1080/14760584.2018.1546582. Epub 2018 Nov 15.

PMID:
30422031
6.

Antibiotic Treatment for Uncomplicated Urinary Tract Infections-Reply.

Huttner A, Leibovici L, Harbarth S.

JAMA. 2018 Sep 25;320(12):1284-1285. doi: 10.1001/jama.2018.10018. No abstract available.

PMID:
30264110
7.

Clinical Reasoning: A 58-year-old woman with systemic scleroderma and progressive cervical cord compression.

Karschnia P, Fulbright RK, Laurans MS, Huttner AJ, Baehring JM.

Neurology. 2018 Sep 25;91(13):e1262-e1264. doi: 10.1212/WNL.0000000000006242. No abstract available.

PMID:
30249680
8.

Metabolic regulation and glucose sensitivity of cortical radial glial cells.

Rash BG, Micali N, Huttner AJ, Morozov YM, Horvath TL, Rakic P.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10142-10147. doi: 10.1073/pnas.1808066115. Epub 2018 Sep 17.

PMID:
30224493
9.

Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline.

Wijma RA, Huttner A, Koch BCP, Mouton JW, Muller AE.

J Antimicrob Chemother. 2018 Nov 1;73(11):2916-2926. doi: 10.1093/jac/dky255.

PMID:
30184207
10.

An ounce of prevention.

Huttner A.

Clin Microbiol Infect. 2018 Oct;24(10):1037-1038. doi: 10.1016/j.cmi.2018.08.016. Epub 2018 Aug 28. No abstract available.

PMID:
30170134
11.

De novo MYH9 mutation in congenital scalp hemangioma.

Fomchenko EI, Duran D, Jin SC, Dong W, Erson-Omay EZ, Antwi P, Allocco A, Gaillard JR, Huttner A, Gunel M, DiLuna ML, Kahle KT.

Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a002998. doi: 10.1101/mcs.a002998. Print 2018 Aug.

12.

CMI and 'primary-care' infections.

Huttner A, Pulcini C.

Clin Microbiol Infect. 2018 Aug;24(8):797-798. doi: 10.1016/j.cmi.2018.05.014. Epub 2018 May 25. No abstract available.

PMID:
29807118
13.

The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli.

Huttner A, Gambillara V.

Clin Microbiol Infect. 2018 Oct;24(10):1046-1050. doi: 10.1016/j.cmi.2018.05.009. Epub 2018 May 24. Review.

PMID:
29803843
14.

Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.

Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, Kosiek K, Martinez de Tejada B, Roux X, Shiber S, Theuretzbacher U, von Dach E, Yahav D, Leibovici L, Godycki-Cwirko M, Mouton JW, Harbarth S.

JAMA. 2018 May 1;319(17):1781-1789. doi: 10.1001/jama.2018.3627.

15.

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.

Huttner A, Agnandji ST, Combescure C, Fernandes JF, Bache EB, Kabwende L, Ndungu FM, Brosnahan J, Monath TP, Lemaître B, Grillet S, Botto M, Engler O, Portmann J, Siegrist D, Bejon P, Silvera P, Kremsner P, Siegrist CA; VEBCON; VSV-EBOVAC; VSV-EBOPLUS Consortia.

Lancet Infect Dis. 2018 Jul;18(7):738-748. doi: 10.1016/S1473-3099(18)30165-8. Epub 2018 Apr 5.

PMID:
29627147
16.

Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?

Muller AE, Huttner B, Huttner A.

Drugs. 2018 Mar;78(4):439-451. doi: 10.1007/s40265-018-0880-z. Review.

PMID:
29476349
17.

Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib.

Marks AM, Bindra RS, DiLuna ML, Huttner A, Jairam V, Kahle KT, Kieran MW.

Pediatr Blood Cancer. 2018 May;65(5):e26969. doi: 10.1002/pbc.26969. Epub 2018 Jan 30.

PMID:
29380516
18.

Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage.

Chang CF, Goods BA, Askenase MH, Hammond MD, Renfroe SC, Steinschneider AF, Landreneau MJ, Ai Y, Beatty HE, da Costa LHA, Mack M, Sheth KN, Greer DM, Huttner A, Coman D, Hyder F, Ghosh S, Rothlin CV, Love JC, Sansing LH.

J Clin Invest. 2018 Feb 1;128(2):607-624. doi: 10.1172/JCI95612. Epub 2017 Dec 18.

19.

The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.

Paspalas CD, Carlyle BC, Leslie S, Preuss TM, Crimins JL, Huttner AJ, van Dyck CH, Rosene DL, Nairn AC, Arnsten AFT.

Alzheimers Dement. 2018 May;14(5):680-691. doi: 10.1016/j.jalz.2017.11.005. Epub 2017 Dec 11.

20.

Disappearing Leukoencephalopathy : A Case of Relapsing-Remitting Intravascular Large B‑Cell Lymphoma with Transient Spontaneous Radiographic Regression.

Chan AM, Huttner A, Baehring J.

Clin Neuroradiol. 2018 Sep;28(3):455-459. doi: 10.1007/s00062-017-0650-4. Epub 2017 Dec 1. No abstract available.

PMID:
29196778
21.

Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice.

Jurado KA, Yockey LJ, Wong PW, Lee S, Huttner AJ, Iwasaki A.

Nat Microbiol. 2018 Feb;3(2):141-147. doi: 10.1038/s41564-017-0060-z. Epub 2017 Nov 20.

22.

CMI policy on antimicrobial stewardship research.

Pulcini C, Huttner A.

Clin Microbiol Infect. 2018 Feb;24(2):91-92. doi: 10.1016/j.cmi.2017.11.006. Epub 2017 Nov 10. No abstract available.

PMID:
29133158
23.

A p190BRhoGAP mutation and prolonged RhoB activation in fatal systemic capillary leak syndrome.

Pierce RW, Merola J, Lavik JP, Kluger MS, Huttner A, Khokha MK, Pober JS.

J Exp Med. 2017 Dec 4;214(12):3497-3505. doi: 10.1084/jem.20162143. Epub 2017 Nov 2.

24.

Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.

Erfe JM, Perry A, McClaskey J, Inzucchi SE, James WS, Eid T, Bronen RA, Mahajan A, Huttner A, Santos F, Spencer D.

J Neurosurg. 2018 Sep;129(3):629-641. doi: 10.3171/2017.3.JNS162245. Epub 2017 Oct 13.

PMID:
29027854
25.

Leiomyosarcoma of the infratemporal fossa with perineurial spread along the right mandibular nerve: a case report.

Barbiero FJ, Huttner AJ, Judson BL, Baehring JM.

CNS Oncol. 2017 Oct;6(4):281-285. doi: 10.2217/cns-2017-0004. Epub 2017 Oct 9.

26.

Neurolymphomatosis of the thoracic sympathetic chain.

Kaulen LD, Foss FM, Fulbright RK, Huttner A, Baehring JM.

Neurology. 2017 Oct 31;89(18):1926-1927. doi: 10.1212/WNL.0000000000004600. Epub 2017 Sep 22. No abstract available.

27.

Multicentric Chordoma : An Uncommon and Incompletely Understood Presentation.

Jones JR, Huttner A, Malhotra A.

Clin Neuroradiol. 2018 Jun;28(2):283-288. doi: 10.1007/s00062-017-0610-z. Epub 2017 Aug 1. No abstract available.

PMID:
28766007
28.

[Lower urinary tract infections in men. Urethritis, cystitis and prostatitis].

Zanella MC, Schoofs F, Huttner B, Huttner A.

Rev Med Suisse. 2017 Apr 12;13(558):808-814. French.

PMID:
28727330
29.

PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia.

Huttner A, Albrich WC, Bochud PY, Gayet-Ageron A, Rossel A, Dach EV, Harbarth S, Kaiser L.

BMJ Open. 2017 Jul 13;7(7):e017996. doi: 10.1136/bmjopen-2017-017996.

30.

New and improved? A review of novel antibiotics for Gram-positive bacteria.

Abbas M, Paul M, Huttner A.

Clin Microbiol Infect. 2017 Oct;23(10):697-703. doi: 10.1016/j.cmi.2017.06.010. Epub 2017 Jun 19. Review.

31.

SOX2 immunity and tissue resident memory in children and young adults with glioma.

Vasquez JC, Huttner A, Zhang L, Marks A, Chan A, Baehring JM, Kahle KT, Dhodapkar KM.

J Neurooncol. 2017 Aug;134(1):41-53. doi: 10.1007/s11060-017-2515-8. Epub 2017 Jun 15.

PMID:
28620836
32.

Surface chemistry governs cellular tropism of nanoparticles in the brain.

Song E, Gaudin A, King AR, Seo YE, Suh HW, Deng Y, Cui J, Tietjen GT, Huttner A, Saltzman WM.

Nat Commun. 2017 May 19;8:15322. doi: 10.1038/ncomms15322.

33.

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.

Huttner A, Combescure C, Grillet S, Haks MC, Quinten E, Modoux C, Agnandji ST, Brosnahan J, Dayer JA, Harandi AM, Kaiser L, Medaglini D, Monath T; VEBCON and VSV-EBOVAC Consortia, Roux-Lombard P, Kremsner PG, Ottenhoff TH, Siegrist CA.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaaj1701. doi: 10.1126/scitranslmed.aaj1701.

PMID:
28404856
34.

Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey.

Dayer JA, Siegrist CA, Huttner A.

PLoS One. 2017 Mar 8;12(3):e0173148. doi: 10.1371/journal.pone.0173148. eCollection 2017.

35.

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial.

Huttner A, Hatz C, van den Dobbelsteen G, Abbanat D, Hornacek A, Frölich R, Dreyer AM, Martin P, Davies T, Fae K, van den Nieuwenhof I, Thoelen S, de Vallière S, Kuhn A, Bernasconi E, Viereck V, Kavvadias T, Kling K, Ryu G, Hülder T, Gröger S, Scheiner D, Alaimo C, Harbarth S, Poolman J, Fonck VG.

Lancet Infect Dis. 2017 May;17(5):528-537. doi: 10.1016/S1473-3099(17)30108-1. Epub 2017 Feb 24.

PMID:
28238601
36.

Fair reporting of study results.

Huttner A, Kaiser L; CMI editors.

Clin Microbiol Infect. 2017 Jun;23(6):345-346. doi: 10.1016/j.cmi.2017.02.015. Epub 2017 Feb 21. No abstract available.

37.

Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy.

Albrich WC, Huttner BD, Huttner A.

JAMA Intern Med. 2017 Feb 1;177(2):283-284. doi: 10.1001/jamainternmed.2016.8574. No abstract available.

PMID:
28166342
38.

Clonal or not clonal? Investigating hospital outbreaks of KPC-producing Klebsiella pneumoniae with whole-genome sequencing.

Ruppé E, Olearo F, Pires D, Baud D, Renzi G, Cherkaoui A, Goldenberger D, Huttner A, François P, Harbarth S, Schrenzel J.

Clin Microbiol Infect. 2017 Jul;23(7):470-475. doi: 10.1016/j.cmi.2017.01.015. Epub 2017 Jan 29.

39.

Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study.

Huwyler T, Lenggenhager L, Abbas M, Ing Lorenzini K, Hughes S, Huttner B, Karmime A, Uçkay I, von Dach E, Lescuyer P, Harbarth S, Huttner A.

Clin Microbiol Infect. 2017 Jul;23(7):454-459. doi: 10.1016/j.cmi.2017.01.005. Epub 2017 Jan 19.

40.

Inequality dynamics in the workplace among microbiologists and infectious disease specialists: a qualitative study in five European countries.

Huttner A, Cacace M, d'Andrea L, Skevaki C, Otelea D, Pugliese F, Tacconelli E.

Clin Microbiol Infect. 2017 May;23(5):332.e1-332.e9. doi: 10.1016/j.cmi.2016.09.015. Epub 2016 Sep 28.

41.

Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.

Muller AE, Verhaegh EM, Harbarth S, Mouton JW, Huttner A.

Clin Microbiol Infect. 2017 Jun;23(6):355-362. doi: 10.1016/j.cmi.2016.08.003. Epub 2016 Aug 17. Review.

42.

Closing the evidence gap in infectious disease: point-of-care randomization and informed consent.

Huttner A, Leibovici L, Theuretzbacher U, Huttner B, Paul M.

Clin Microbiol Infect. 2017 Feb;23(2):73-77. doi: 10.1016/j.cmi.2016.07.029. Epub 2016 Aug 3. Review.

43.

Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.

Saucier-Sawyer JK, Seo YE, Gaudin A, Quijano E, Song E, Sawyer AJ, Deng Y, Huttner A, Saltzman WM.

J Control Release. 2016 Jun 28;232:103-12. doi: 10.1016/j.jconrel.2016.04.006. Epub 2016 Apr 8.

44.

Ectopic intracranial germinoma.

Shankar S, Wu X, Kalra VB, Huttner AJ, Malhotra A.

J Clin Neurosci. 2016 Sep;31:192-5. doi: 10.1016/j.jocn.2016.02.013. Epub 2016 Apr 2.

PMID:
27050919
45.

An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model.

Nelson RE, Jones M, Leecaster M, Samore MH, Ray W, Huttner A, Huttner B, Khader K, Stevens VW, Gerding D, Schweizer ML, Rubin MA.

PLoS One. 2016 Mar 31;11(3):e0152248. doi: 10.1371/journal.pone.0152248. eCollection 2016.

46.

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.

Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, Kaya G, Krähling V, Kwilas S, Lemaître B, Matthey A, Silvera P, Becker S, Fast PE, Moorthy V, Kieny MP, Kaiser L, Siegrist CA; VSV-Ebola Consortium.

Lancet Infect Dis. 2015 Oct;15(10):1156-1166. doi: 10.1016/S1473-3099(15)00154-1. Epub 2015 Aug 4.

PMID:
26248510
47.

Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?

Huttner A, Harbarth S, Hope WW, Lipman J, Roberts JA.

J Antimicrob Chemother. 2015 Dec;70(12):3178-83. doi: 10.1093/jac/dkv201. Epub 2015 Jul 17. Review.

PMID:
26188037
48.

Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials.

Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW.

J Antimicrob Chemother. 2015 Sep;70(9):2456-64. doi: 10.1093/jac/dkv147. Epub 2015 Jun 11. Review.

PMID:
26066581
49.

A 15-year-old girl with a rapidly progressing tumor-like lesion.

Keung B, Huttner A.

Neuropathology. 2015 Oct;35(5):497-501. doi: 10.1111/neup.12207. Epub 2015 May 25. No abstract available.

PMID:
26011248
50.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, Adegnika AA, Altfeld M, Auderset F, Bache EB, Biedenkopf N, Borregaard S, Brosnahan JS, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling SK, Finckh A, Goncalves AR, Grobusch MP, Hooper J, Jambrecina A, Kabwende AL, Kaya G, Kimani D, Lell B, Lemaître B, Lohse AW, Massinga-Loembe M, Matthey A, Mordmüller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl FR, Staines HM, Strecker T, Stubbe HC, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny MP, Bejon P, Kremsner PG, Addo MM, Siegrist CA.

N Engl J Med. 2016 Apr 28;374(17):1647-60. doi: 10.1056/NEJMoa1502924. Epub 2015 Apr 1.

Supplemental Content

Loading ...
Support Center